Related Experiment Videos

Biotransformation of sisomicin to gentamicin C2b

B K Lee, J V Bailey, R G Condon

    Antimicrobial Agents and Chemotherapy
    |September 1, 1977
    PubMed

    Insights

    Sisomicin biotransformation yielded gentamicin C(2b) via Micromonospora rhodorangea. Key mechanisms included 6’-N-methylation and (4’-5’)-reduction, with methylation progression tracked using isotopes.

    Area of Science:

    • Microbiology
    • Biochemistry
    • Molecular Biology

    Background:

    • Aminoglycoside antibiotics are crucial in treating bacterial infections.
    • Sisomicin and gentamicin are structurally related aminoglycosides with distinct clinical applications.
    • Microbial biotransformation offers a pathway for modifying antibiotic structures.

    Purpose of the Study:

    • To investigate the biotransformation of sisomicin to gentamicin C(2b) using Micromonospora rhodorangea.
    • To elucidate the biochemical mechanisms underlying this specific microbial transformation.
    • To monitor the progression of methylation during the biotransformation process.

    Main Methods:

    • Cultivation of Micromonospora rhodorangea NRRL 5326.
    • Biochemical assays to identify and quantify sisomicin and gentamicin C(2b).
    • Isotope labeling techniques to track the methylation pathway.

    Main Results:

    • Successful transformation of sisomicin to gentamicin C(2b) was achieved.
    • The biotransformation involves two primary mechanisms: 6'-N-methylation and (4'-5')-reduction.
    • The progression of the 6'-N-methylation step was successfully monitored using isotopic methods.

    Conclusions:

    • Micromonospora rhodorangea NRRL 5326 efficiently biotransforms sisomicin into gentamicin C(2b).
    • The study identified 6'-N-methylation and (4'-5')-reduction as key steps in this conversion.
    • Isotope techniques are effective for studying methylation in antibiotic biotransformation.

    Related Concept Videos